CN Patent
CN105518019A — 肽环氧基酮的合成
Assigned to Sandoz AG · Expires 2016-04-20 · 10y expired
What this patent protects
提供了制备肽环氧基酮的改进方法,包括可以在制备卡非佐米和其它肽环氧基酮的方法中用作中间体的新化合物。
USPTO Abstract
提供了制备肽环氧基酮的改进方法,包括可以在制备卡非佐米和其它肽环氧基酮的方法中用作中间体的新化合物。
Drugs covered by this patent
- Kyprolis (carfilzomib) · Amgen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.